Neuros Medical
Aliso Viejo, OH, United States · Biotechnology, Health Care, Medical · 48 employees
Neuros is dedicated to helping amputees suffering from chronic phantom and residual limb pain find lasting relief. Our mission is to reduce pain-induced opioid dependency, enhance mental well-being, and restore quality of life. We are developing a novel technology designed to turn this vision into reality.
Funding history
- Funding Round — $56.0M — Aug 2025
- Series series d — $56.0M — Jul 2025
- Funding Round — $20.0M — Sep 2023
- Funding Round — $8.2M — Dec 2022
- Series series b — $38.0M — Jan 2021
Recent signals
- Aug 06, 2025: Raised $56.0M
- Jul 09, 2025: Raised $56.0M in Series series d
- Jun 05, 2024: Neuros Medical, Inc. Appoints Zach Stassen as Chief Financial Officer and Kirk Ellis as Vice President of U.S. Sales
- Sep 25, 2023: Raised $20.0M
- Dec 19, 2022: Raised $8.2M
- Jan 07, 2021: Raised $38.0M in Series series b
- Nov 03, 2020: Raised $37.0M
- Jun 10, 2020: Raised $2.2M
See plans & pricing → Track Neuros Medical’s funding, hiring, and signals — with verified contacts — on Fundz.